206 related articles for article (PubMed ID: 22032294)
21. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
22. HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases.
Swets M; König MH; Zaalberg A; Dekker-Ensink NG; Gelderblom H; van de Velde CJ; van den Elsen PJ; Kuppen PJ
Hum Immunol; 2016 Sep; 77(9):773-9. PubMed ID: 26968946
[TBL] [Abstract][Full Text] [Related]
23. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
Wada H; Matsumoto N; Maenaka K; Suzuki K; Yamamoto K
Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
[TBL] [Abstract][Full Text] [Related]
25. Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis.
Warren HS; Christiansen FT; Witt CS
Br J Haematol; 2003 Jun; 121(5):793-804. PubMed ID: 12780796
[TBL] [Abstract][Full Text] [Related]
26. Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer.
Zhen ZJ; Ling JY; Cai Y; Luo WB; He YJ
Med Oncol; 2013 Mar; 30(1):482. PubMed ID: 23377987
[TBL] [Abstract][Full Text] [Related]
27. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.
Borrego F; Kabat J; Kim DK; Lieto L; Maasho K; Peña J; Solana R; Coligan JE
Mol Immunol; 2002 Feb; 38(9):637-60. PubMed ID: 11858820
[TBL] [Abstract][Full Text] [Related]
28. Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
Sarkar S; van Gelder M; Noort W; Xu Y; Rouschop KM; Groen R; Schouten HC; Tilanus MG; Germeraad WT; Martens AC; Bos GM; Wieten L
Cancer Immunol Immunother; 2015 Aug; 64(8):951-63. PubMed ID: 25920521
[TBL] [Abstract][Full Text] [Related]
29. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
30. Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.
Hiraoka N; Ino Y; Hori S; Yamazaki-Itoh R; Naito C; Shimasaki M; Esaki M; Nara S; Kishi Y; Shimada K; Nakamura N; Torigoe T; Heike Y
Cancer Sci; 2020 Aug; 111(8):3057-3070. PubMed ID: 32495519
[TBL] [Abstract][Full Text] [Related]
31. Senescent cells evade immune clearance via HLA-E-mediated NK and CD8
Pereira BI; Devine OP; Vukmanovic-Stejic M; Chambers ES; Subramanian P; Patel N; Virasami A; Sebire NJ; Kinsler V; Valdovinos A; LeSaux CJ; Passos JF; Antoniou A; Rustin MHA; Campisi J; Akbar AN
Nat Commun; 2019 Jun; 10(1):2387. PubMed ID: 31160572
[TBL] [Abstract][Full Text] [Related]
32. Implications of HLA-E allele expression and different HLA-E ligand diversity for the regulation of NK cells.
Maier S; Grzeschik M; Weiss EH; Ulbrecht M
Hum Immunol; 2000 Nov; 61(11):1059-65. PubMed ID: 11137208
[TBL] [Abstract][Full Text] [Related]
33. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
34. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
35. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer.
Ducoin K; Oger R; Bilonda Mutala L; Deleine C; Jouand N; Desfrançois J; Podevin J; Duchalais E; Cruard J; Benlalam H; Labarrière N; Bossard C; Jarry A; Gervois-Segain N
Oncoimmunology; 2022; 11(1):2046931. PubMed ID: 35295095
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
37. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
38. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.
Krijgsman D; Roelands J; Andersen MN; Wieringa CHLA; Tollenaar RAEM; Hendrickx W; Bedognetti D; Hokland M; Kuppen PJK
Mol Immunol; 2020 Dec; 128():205-218. PubMed ID: 33142138
[TBL] [Abstract][Full Text] [Related]
39. HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.
Pannemans K; Broux B; Goris A; Dubois B; Broekmans T; Van Wijmeersch B; Geraghty D; Stinissen P; Hellings N
Mult Scler; 2014 Jun; 20(7):790-801. PubMed ID: 24144875
[TBL] [Abstract][Full Text] [Related]
40. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
